{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:43Z","timestamp":1761519103959},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00198-014-2760-z","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T10:50:05Z","timestamp":1406112605000},"page":"2263-2269","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection"],"prefix":"10.1007","volume":"25","author":[{"given":"T.","family":"Porcelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Maffezzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Foc\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giustina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Quiros-Roldan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"2760_CR1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","volume":"21","author":"JH Arnsten","year":"2007","unstructured":"Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS (2007) Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21:617\u2013623","journal-title":"AIDS"},{"key":"2760_CR2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1359\/JBMR.0301246","volume":"19","author":"C Amiel","year":"2004","unstructured":"Amiel C, Ostertag A, Slama L, Baudoin C, N\u2019Guyen T, Lajeunie E et al (2004) BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res 19:402\u2013409","journal-title":"J Bone Miner Res"},{"key":"2760_CR3","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","volume":"24","author":"A Bonjoch","year":"2010","unstructured":"Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L et al (2010) High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 24:2827\u20132833","journal-title":"AIDS"},{"key":"2760_CR4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","volume":"17","author":"D Bruera","year":"2003","unstructured":"Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS 17:1917\u20131923","journal-title":"AIDS"},{"key":"2760_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","volume":"22","author":"C Cazanave","year":"2008","unstructured":"Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N et al (2008) Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS 22:395\u2013402","journal-title":"AIDS"},{"key":"2760_CR6","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","volume":"14","author":"P Tebas","year":"2000","unstructured":"Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL et al (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63\u2013F67","journal-title":"AIDS"},{"key":"2760_CR7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-200109070-00019","volume":"15","author":"AL Moore","year":"2001","unstructured":"Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Phillips AN et al (2001) Reduced bone mineral density in HIV-positive individuals. AIDS 15:1731\u20131733","journal-title":"AIDS"},{"key":"2760_CR8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","volume":"15","author":"H Knobel","year":"2001","unstructured":"Knobel H, Guelar A, Vallecillo G, Nogu\u00e9s X, D\u00edez A (2001) Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 15:807\u2013808","journal-title":"AIDS"},{"key":"2760_CR9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bone.2005.11.001","volume":"38","author":"A Fausto","year":"2006","unstructured":"Fausto A, Bongiovanni M, Cicconi P, Menicagli L, Ligab\u00f2 EV, Melzi S et al (2006) Potential predictive factors of osteoporosis in HIV-positive subjects. Bone 38:893\u2013897","journal-title":"Bone"},{"key":"2760_CR10","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20:2165\u20132174","journal-title":"AIDS"},{"key":"2760_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2265.2006.02572.x","volume":"65","author":"MJ Bolland","year":"2006","unstructured":"Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB et al (2006) Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy. Clin Endocrinol 65:191\u2013197","journal-title":"Clin Endocrinol"},{"key":"2760_CR12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e3181893e8e","volume":"49","author":"DL Jacobson","year":"2008","unstructured":"Jacobson DL, Spiegelman D, Knox TK, Wilson IB (2008) Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. J Acquir Immune Defic Syndr 49:298\u2013308","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2760_CR13","doi-asserted-by":"crossref","first-page":"e17217","DOI":"10.1371\/journal.pone.0017217","volume":"6","author":"JA Womack","year":"2011","unstructured":"Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, Gulanski B et al (2011) Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One 6:e17217","journal-title":"PLoS One"},{"key":"2760_CR14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.bone.2011.01.015","volume":"48","author":"K Briot","year":"2011","unstructured":"Briot K, Kolta S, Flandre P, Boue F, Van Ngo P, Cohen-Codar I et al (2011) Prospective one-year bone loss in treatment-naive HIVR men and women on single or multiple drug HIV therapies. Bone 48:1133\u20131139","journal-title":"Bone"},{"key":"2760_CR15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","volume":"23","author":"C Duvivier","year":"2009","unstructured":"Duvivier C, Kolta S, Assoumou L, Ghosn J, Rozenberg S, Murphy RL et al (2009) Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS 23:817\u2013824","journal-title":"AIDS"},{"key":"2760_CR16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD et al (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 292:191\u2013201","journal-title":"JAMA"},{"key":"2760_CR17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1468-1293.2007.00525.x","volume":"9","author":"P Rivas","year":"2008","unstructured":"Rivas P, Gorgolas M, Garcia-Delgado R, Diaz-Curie M, Goyenechea A, Fernandez-Guerrero M (2008) Evolution of bone mineral density in AIDS patients on treatment with zidovudine\/lamivudine plus abacavir or lopinavir\/ritonavir. HIV Med 9:89\u201395","journal-title":"HIV Med"},{"key":"2760_CR18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/QAD.0b013e32832c4947","volume":"23","author":"MG Vonderen Van","year":"2009","unstructured":"Van Vonderen MG, Lips P, van Agtmael MA, Hassink EA, Brinkman K, Geerlings SE et al (2009) First line zidovudine\/lamivudine\/lopinavir\/ritonavir leads to greater bone loss compared to nevirapine\/lopinavir\/ritonavir. AIDS 23:1367\u20131376","journal-title":"AIDS"},{"key":"2760_CR19","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","volume":"203","author":"GA McComsey","year":"2011","unstructured":"McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P et al (2011) Bone mineral density and fractures in antiretroviral-na\u00efve persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224 s, a substudy of ACTG A5202. J Infect Dis 203:1791\u20131801","journal-title":"J Infect Dis"},{"key":"2760_CR20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2265.2007.02875.x","volume":"67","author":"MJ Bolland","year":"2007","unstructured":"Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB et al (2007) Bone mineral density remains stable in HAART treated HIV-infected men over 2 years. Clin Endocrinol 67:270\u2013275","journal-title":"Clin Endocrinol"},{"key":"2760_CR21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","volume":"36","author":"K Mondy","year":"2003","unstructured":"Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D et al (2003) Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482\u2013490","journal-title":"Clin Infect Dis"},{"key":"2760_CR22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","volume":"15","author":"D Nolan","year":"2001","unstructured":"Nolan D, Upton R, McKinnon E, John M, James I, Adler B et al (2001) Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 15:1275\u20131280","journal-title":"AIDS"},{"key":"2760_CR23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","volume":"42","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467\u2013475","journal-title":"Bone"},{"key":"2760_CR24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jocd.2007.12.012","volume":"11","author":"DB Hans","year":"2008","unstructured":"Hans DB, Shepherd JA, Schwartz EN, Reid DM, Blake GM, Fordham JN et al (2008) Peripheral dual-energy X-ray absorptiometry in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom 11:188\u2013206","journal-title":"J Clin Densitom"},{"key":"2760_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-012-9691-2","volume":"42","author":"JF Griffith","year":"2012","unstructured":"Griffith JF, Genant HK (2012) New advances in imaging osteoporosis and its complications. Endocrine 42:39\u201351","journal-title":"Endocrine"},{"key":"2760_CR26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","volume":"51","author":"GA McComsey","year":"2010","unstructured":"McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS et al (2010) Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 51:937\u2013946","journal-title":"Clin Infect Dis"},{"key":"2760_CR27","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1093\/infdis\/jis199","volume":"205","author":"V Walker Harris","year":"2012","unstructured":"Walker Harris V, Brown TT (2012) Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis 205:S391\u2013S398","journal-title":"J Infect Dis"},{"key":"2760_CR28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12020-011-9586-7","volume":"41","author":"C Torti","year":"2012","unstructured":"Torti C, Mazziotti G, Soldini PA, Foc\u00e0 E, Maroldi R, Gotti D et al (2012) High prevalence of radiological vertebral fractures in HIV-infected males. Endocrine 41:512\u2013517","journal-title":"Endocrine"},{"key":"2760_CR29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","volume":"359","author":"SR Cummings","year":"2002","unstructured":"Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761\u20131767","journal-title":"Lancet"},{"key":"2760_CR30","unstructured":"European AIDS Clinical Society (2013) Prevention and management of non-infectious comorbidities in HIV. Version 7.0. http:\/\/eacsociety.org\/Guidelines.aspx . Accessed 17 Jul 2014)"},{"key":"2760_CR31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2265.2012.04452.x","volume":"77","author":"J Pepe","year":"2012","unstructured":"Pepe J, Isidori AM, Falciano M, Iaiani G, Salotti A, Diacinti D et al (2012) The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture. Clin Endocrinol 77:672\u2013678","journal-title":"Clin Endocrinol"},{"key":"2760_CR32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","volume":"41","author":"G Mazziotti","year":"2012","unstructured":"Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A (2012) New understanding and treatments for osteoporosis. Endocrine 41:58\u201369","journal-title":"Endocrine"},{"key":"2760_CR33","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1359\/jbmr.2000.15.7.1368","volume":"15","author":"A Oleksik","year":"2000","unstructured":"Oleksik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Miner Res 15:1368\u20131375","journal-title":"J Bone Miner Res"},{"key":"2760_CR34","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2008-0791","volume":"93","author":"G Mazziotti","year":"2008","unstructured":"Mazziotti G, Bianchi A, Bonadonna S et al (2008) Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 93:4649\u20134655","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","volume":"39","author":"A Angeli","year":"2006","unstructured":"Angeli A, Guglielmi G, Dovio A et al (2006) High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39:253\u2013259","journal-title":"Bone"},{"key":"2760_CR36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","volume":"123","author":"G Mazziotti","year":"2010","unstructured":"Mazziotti G, Canalis E, Giustina A (2010) Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 123:877\u2013884","journal-title":"Am J Med"},{"key":"2760_CR37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319\u20131328","journal-title":"Osteoporos Int"},{"key":"2760_CR38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-10-0125","volume":"163","author":"G Mazziotti","year":"2010","unstructured":"Mazziotti G, Porcelli T, Bianchi A, Cimino V, Patelli I, Mejia C et al (2010) Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. Eur J Endocrinol 163:15\u201320","journal-title":"Eur J Endocrinol"},{"key":"2760_CR39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12020-011-9462-5","volume":"39","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Porcelli T, Mormando M, De Menis E, Bianchi A, Mejia C et al (2011) Vertebral fractures in males with prolactinoma. Endocrine 39:288\u2013293","journal-title":"Endocrine"},{"key":"2760_CR40","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1210\/jc.2013-1460","volume":"98","author":"G Mazziotti","year":"2013","unstructured":"Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A et al (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98:3402\u20133410","journal-title":"J Clin Endocrinol Metab"},{"key":"2760_CR41","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","volume":"44","author":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis","year":"2001","unstructured":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44:1496\u20131503","journal-title":"Arthritis Rheum"},{"key":"2760_CR42","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR et al (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 62:1515\u20131526","journal-title":"Arthritis Care Res"},{"key":"2760_CR43","first-page":"1001","volume":"27","author":"DP Wanner","year":"2009","unstructured":"Wanner DP, Tyndall A, Walker UA (2009) Tenofovir-induced osteomalacia. Clin Exp Rheumatol 27:1001\u20131003","journal-title":"Clin Exp Rheumatol"},{"key":"2760_CR44","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/cid\/cit538","volume":"57","author":"PM Grant","year":"2013","unstructured":"Grant PM, Kitch D, McComsey GA, Dube MP, Haubrich R, Huang J et al (2013) Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis 57:1483\u20131488","journal-title":"Clin Infect Dis"},{"key":"2760_CR45","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/jbmr.1967","volume":"28","author":"TT Brown","year":"2013","unstructured":"Brown TT (2013) HIV: an under-recognized secondary cause of osteoporosis? J Bone Miner Res 28:1256\u20131258","journal-title":"J Bone Miner Res"},{"key":"2760_CR46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.17925\/EE.2014.10.01.79","volume":"10","author":"F Maffezzoni","year":"2014","unstructured":"Maffezzoni F, Porcelli T, Karamouzis I et al (2014) Osteoporosis in human immunodeficiency virus patients\u2014an emerging clinical concern. Eur Endocrinol 10:79\u201383","journal-title":"Eur Endocrinol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2760-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2760-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2760-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:15:12Z","timestamp":1558624512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2760-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2760"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2760-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]}}}